Tyra Biosciences, Inc.
TYRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001863127
In the last 90 days, Tyra Biosciences, Inc. insiders filed 1 open-market purchase and 0 sales; 168 institutions reported holding it in 13F filings for Q2 2026, worth $2.22B in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Tyra Biosciences, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 48 | 49 | +1 |
| Shares | 35.7M | 35.7M | −51.1K (−0.1%) |
| Value | $255.6M | $313.8M | +$58.2M (+22.8%) |
New holders (4)
Institutions that held Tyra Biosciences, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sepio Capital, LP | 10,625 | $93.0K | 0.01% |
| Fishman Jay A Ltd | 10,500 | $92.3K | 0.01% |
| UBS Group AG | 91 | $1.00K | 0.00% |
| Ellevest, Inc. | 27 | $0 | 0.00% |
Sold out (3)
Institutions that held Tyra Biosciences, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Susquehanna International Group, LLP | 16,663 | $119.0K |
| Bailard, Inc. | 12,910 | $92.0K |
| Advisor Group Holdings, Inc. | 1 | $0 |